Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Axsome Therapeutics Inc (NASDAQ: AXSM) improved recently. AXSM’s current Value Trend Rating is C and the prior Rating was D. Details supporting this higher rating are included in our next report.
Recent Price Action
On 2/21/25, Axsome Therapeutics Inc (NASDAQ: AXSM) stock enjoyed a very large increase of 6.7%, closing at $137.75. Moreover, this advance was accompanied by above average trading volume at 146% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 4.7% during the last week.
Current PriceTarget Research Rating
Axsome Therapeutics has a current Value Trend Rating of C (Neutral). This VT Rating improved in recent days from D previously. The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Axsome Therapeutics has a poor Appreciation Score of 30 but a slightly positive Power Rating of 69, with the Neutral Value Trend Rating the result.
Be the first to comment